Curant Health on GPB, Our Prescription for Growth

Recently, Curant COO Marc O’Connor spoke with Renay San Miguel from Georgia Public Broadcasting on the Curant’s prescription for growth. In addition to its superior patient care model, with an established 98% retention rate, Curant’s financial success has caught the attention of industry leaders. Since its inception in 2000, Curant has been recognized by industry… read more

340B & HIV Treatment: The Lifesaving Story of Robert W.

Presenting with a CD4 count of only 21, doctors gave Robert W. mere months to live. Weighing only 98 pounds, his HIV had progressed to Stage 3 AIDS, and he was on his deathbed. Robert had been prescribed seven different HIV medications and had a long history of struggling with his HIV treatment compliance due… read more

Dear Biopharma Manufacturers: Your At-Risk Day Has Arrived

The writing has been on the wall from some time. The push for value-based care has had a domino effect on biopharmaceutical manufacturers. The new industry trend will be for them to go “at-risk” in negotiations with payers and PBMs for new high-cost specialty therapies. Factors that increase the need for biopharma manufacturers to go… read more

The top 4 things you should know about the state of HIV treatment

What are the new questions regarding HIV treatment? When it comes to hepatitis C, Gilead drugs Harvoni and Sovaldi have validated their value-based care.  If faced with the options of spending $577,000 on a liver transplant or $94,500 on a course of Harvoni for hepatitis C, it’s a no brainer which option is more favorable…. read more

New Curant Cares Award Recognizes Employee Morale

For employees at Curant Health, caring for patients is a fundamental job role. Advocating on behalf of our patients, verifying and collaborating with insurance payors to ensure accurate flow of information and medication coverage are all daily responsibilities that require a high degree of care and compassion. At Curant Health, we witness our employees dutifully… read more

The Who and What of ACG 2015

ACG 2015 was a remarkable mixture of clinicians, manufacturers and medical device companies focused on the sharing the new processes, drugs and technology targeted to the gastroenterology space. In addition to IBD-related topics, hepatitis c and new medication therapies were the topic of much discussion. As expected, clinicians provided most of this year’s most valuable conference… read more

Media contact: Kristin Lindsey, Marketing Director at 866-437-8040, extension 253 or

Menu Title